| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 02/20/2003 | CA2456369A1 Proteins associated with cell growth, differentiation, and death |
| 02/20/2003 | CA2456010A1 Phosphorylated histone h2b as an apoptosis marker |
| 02/20/2003 | CA2453995A1 Tacis and br3 polypeptides and uses thereof |
| 02/20/2003 | CA2451919A1 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof |
| 02/20/2003 | CA2450780A1 Novel recombinant gene expression method by stop codon suppression |
| 02/19/2003 | EP1284290A1 Increase of the expression levels of factor VIII by insertion of spliceable nucleotide sequences into factor VIII cDNA |
| 02/19/2003 | EP1284288A1 Human apoptosis-associated genes and human apoptosis-associated proteins produced thereby |
| 02/19/2003 | EP1283886A2 Intracellular signaling proteins |
| 02/19/2003 | EP1283882A1 Ssa-56kda polypeptide and its fragments and polynucleotides encoding said polypeptides and therapeutic uses |
| 02/19/2003 | EP1283869A2 Novel bee venom polypeptides and methods of use thereof |
| 02/19/2003 | EP1283849A2 Human receptor proteins; related reagents and methods |
| 02/19/2003 | EP1283848A2 Protein complexes and assays for screening anti-cancer agents |
| 02/19/2003 | EP1283721A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 02/19/2003 | EP1206561B1 Method for production of proteinaceous substances |
| 02/19/2003 | EP1056777A4 Ligand receptors and uses therefor |
| 02/19/2003 | EP0758381B1 Biologically active eph family ligands |
| 02/19/2003 | CN1398299A BZIP type transcripton factors regulating expression of rice storage protein |
| 02/19/2003 | CN1398188A Boltuminum toxin pharmaceutical compsns |
| 02/19/2003 | CN1398162A Use of acid-stable proteases in animal feed |
| 02/19/2003 | CN1398161A Use of acid-stable subtilisin proteases in animal feed |
| 02/19/2003 | CN1101702C Compound capsules contg. granulocyte colony stimulating factor and polyose |
| 02/18/2003 | US6521750 Nucleotide sequence coding human protein for use in treatment of osteoporosis and bone disorders |
| 02/18/2003 | US6521749 GL50 nucleic acids and uses therefor |
| 02/18/2003 | US6521746 Leukotoxin polypeptide fused to gonadotropin releasing hormone/factor multimer; increased immunogenicity |
| 02/18/2003 | US6521743 Monoclonal antibodies; screening and diagnosis of Alzheimer*s, Parkinson*s, Huntington*s, neurodegenerative, amyotrophic lateral sclerosis, Creutzfeldt-Joseph's disease, and apoptosis-concerning protein diseases |
| 02/18/2003 | US6521450 Cells expressing a modified regulator of complement activation |
| 02/18/2003 | US6521442 Polynucleotide compositions encoding broad spectrum δ-endotoxins |
| 02/18/2003 | US6521441 Staphylococcus aureus genes and polypeptides |
| 02/18/2003 | US6521440 Proteases from gram-positive organisms |
| 02/18/2003 | US6521436 Gene expression; drug screening for antiarthritic agents; bone disorders |
| 02/18/2003 | US6521426 Incubation with heper adenovirus vector; gene expression of proteins required for genomic replication |
| 02/18/2003 | US6521423 Intracellular production of Hepatitis C E2 polypeptides |
| 02/18/2003 | US6521422 Fhm, a novel member of the TNF ligand supergene family |
| 02/18/2003 | US6521419 Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| 02/18/2003 | US6521413 Bioassay; monitoring cells for changes in ion channel activity |
| 02/18/2003 | US6521412 Drug screening for anticarcinogenic agents and agents to treat atherosclerosis and neurodegenerative disorders |
| 02/18/2003 | US6521407 Methods for determining chemosensitivity of cancer cells based upon expression of negative and positive signal transduction factors |
| 02/18/2003 | US6521404 Gene expression of library bacteriophage particles with very light domain antibodies and synthetic very heavy antibodies displayed on surface |
| 02/18/2003 | US6521403 Epitopes in viral envelope proteins and specific antibodies directed against these epitopes: use for detection of HCV viral antigen in host tissue |
| 02/18/2003 | US6521230 CD25 binding molecules |
| 02/18/2003 | CA2075366C Immunologically active peptides or polypeptides from the parvovirus b19 |
| 02/18/2003 | CA2071211C Immunoassays for and monoclonal antibodies to prothrombin activation peptides and their degradation products |
| 02/18/2003 | CA2067031C Dna coding for human cell surface antigen |
| 02/18/2003 | CA2064331C Vascular endothelial cell growth factor c subunit |
| 02/18/2003 | CA2061382C Method for producing cysteine-free peptide |
| 02/17/2003 | CA2356390A1 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 02/15/2003 | CA2392309A1 Neuropeptide receptor and uses thereof |
| 02/13/2003 | WO2003012451A2 Methods for detecting of intermoleculair interactions using protein arrays |
| 02/13/2003 | WO2003012448A1 Engineering of living cells for the expression of holo-phycobiliprotein-based constructs |
| 02/13/2003 | WO2003012444A1 Method and kit for typing feline blood |
| 02/13/2003 | WO2003012143A1 Genes and snps associated with eating disorders |
| 02/13/2003 | WO2003012127A2 Assay for identifying inhibitors of hiv rt dimerization |
| 02/13/2003 | WO2003012126A2 Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| 02/13/2003 | WO2003012114A2 Methods of rna and protein synthesis |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003012104A1 Novel g protein-coupled receptor protein and dna thereof |
| 02/13/2003 | WO2003012098A1 Modified yeast showing high secretion productivity of foreign protein and process for producing foreign protein using the yeast |
| 02/13/2003 | WO2003012069A2 Compositions and methods for generating chimeric heteromultimers |
| 02/13/2003 | WO2003012068A2 Novel fusion proteins and assays for molecular binding |
| 02/13/2003 | WO2003012044A2 Hagfish cathelin-associated antimicrobial peptides and genes |
| 02/13/2003 | WO2003012035A2 Commercial use of arabidopsis for production of human and animal therapeutic and diagnostic proteins |
| 02/13/2003 | WO2003012034A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/13/2003 | WO2003011899A2 Antigenic polypeptides |
| 02/13/2003 | WO2003011898A2 Synthetic or natural peptides binding protein phosphatase 2a, identification method and uses |
| 02/13/2003 | WO2003011893A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 02/13/2003 | WO2003011878A2 Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity |
| 02/13/2003 | WO2003011106A2 Internal image antibodies for optical imaging and therapy |
| 02/13/2003 | WO2002096948A9 Engineered tetravalent antibodies and methods of use |
| 02/13/2003 | WO2002085924A9 ANTI-α3(IV)NC1 MONOCLONAL ANTIBODIES AND ANIMAL MODEL FOR HUMAN ANTI-GLOMERULAR BASEMENT MEMBRANE AUTOANTIBODY DISEASE |
| 02/13/2003 | WO2002079228A3 Isolated human protease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 02/13/2003 | WO2002078638A3 Morpholino imaging and therapy |
| 02/13/2003 | WO2002070648A3 Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates |
| 02/13/2003 | WO2002069907A3 Anti-neovasculature preparations for cancer |
| 02/13/2003 | WO2002066514A3 Artificial fusion proteins with reduced immunogenicity |
| 02/13/2003 | WO2002065992A3 A cell therapy method for the treatment of tumors |
| 02/13/2003 | WO2002053723B1 Degradation and detection of tse infectivity |
| 02/13/2003 | WO2002046192A3 Thioether substituted imidazoquinolines |
| 02/13/2003 | WO2002040688A9 Maize yellow stripe1 and related genes |
| 02/13/2003 | WO2002038805A3 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 02/13/2003 | WO2002032958A3 Polynucleotide and polypeptide sequences of human dendritic cell immunoreceptors |
| 02/13/2003 | WO2002024874A3 Methods for preparing interferon producing dentitric cells |
| 02/13/2003 | WO2002018443A3 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 02/13/2003 | US20030033637 Generation of transforming growth factor protein in plants; obtain plant, transform with vector containing transforming growth factor, culture and propagate plant, recover protein |
| 02/13/2003 | US20030033636 Expression of eukaryotic peptides in plant plastids |
| 02/13/2003 | US20030032792 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of gastrointestinal, crohn's, inflammatory bowel, diabetes and cancer, |
| 02/13/2003 | US20030032791 Nucleotide sequences coding polypeptide for use in the treatment of metabolic, reproductive and eating disorders |
| 02/13/2003 | US20030032787 Nucleotide sequences coding polypeptide for use in the treatment and prevention of malarial infection |
| 02/13/2003 | US20030032775 Effector proteins of rapamycin |
| 02/13/2003 | US20030032588 Glucagon antagonists |
| 02/13/2003 | US20030032166 Aortic carboxypeptidase-like protein and nucleic acids encoding same |
| 02/13/2003 | US20030032156 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 02/13/2003 | US20030032155 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032146 Enzyme/tag binding and detection system |
| 02/13/2003 | US20030032144 Nucleic acid constructs useful for glucose regulated production of human insulin in somatic cell lines |
| 02/13/2003 | US20030032138 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032135 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032119 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/13/2003 | US20030032097 DNA encoding human vanilloid receptor VR3 |
| 02/13/2003 | US20030032093 Production of secreted polypeptides |
| 02/13/2003 | US20030032085 An expression cassette comprising a transcriptional initiation region, consisting of a 5' non-coding region regulating the transcription of patched protein, a marker gene, and a transcriptional termination region |